Open to all conference attendees.

Hear from current innovators and vote for National Alliance Innovator of the Year 

Innovator - Outcome Referrals, Inc. Unlock Better Behavioral Health Outcomes for Your Workforce with Express Access

Reducing time to mental healthcare and total cost through seamless integration with current health plans and vendors through a neutral, outcomes-based, bias-free infrastructure once seemed futuristic. The future is now.

This compelling case study demonstrates how the Outcome Referrals health platform is improving outcomes by up to five times. Rather than an owned or promoted network, mental health providers compete based on real-world results, transforming referrals from volume to value driven. The result is speedier access, better matches, and lasting recovery.

Innovator - CheckMySpot® - Direct Access Platform™ for Early Skin Cancer Detection: Empowering Access, Eliminating Expense, Enhancing Outcomes

CheckMySpot® is a transformative Direct Access Platform™ that accelerates skin cancer diagnosis and treatment, improving survival rates, surgical outcomes, and reducing disease-related costs. By empowering employees with immediate access to skin cancer experts, this digital health solution enables earlier cancer detection, leading to less anxiety, lower costs, and fewer catastrophic claims. It also helps uncover hidden costs associated with delayed diagnoses, such as absenteeism, reduced productivity, or disability—delivering real savings to employers and healthier outcomes for their employees.

Validated by the Validation Institute, the platform delivers measurable ROI including over 7% reduction in skin lesion-related healthcare spending, fewer and less severe claims, and higher employee productivity. With seamless HR integration, zero-lift deployment, and straightforward pricing, CheckMySpot® fills a vital gap in the care continuum, helping employers and healthcare purchasers build a smarter benefit infrastructure and lower direct healthcare costs.

Innovator - Fresh Tri: The Triple Threat Against GLP-1 Cost Overruns

GLP-1 drugs are transforming obesity and diabetes care—but they’re also blowing up healthcare budgets. Fresh Tri is a behavioral science platform purpose-built to tackle the GLP-1 cost crisis on three fronts: As a utilization management tool; as a medication companion to improve outcomes and reduce dropout; and as a long-term lifestyle solution to sustain weight loss off-medication. In this 10-minute innovation pitch, learn how Fresh Tri addresses payer pain, provider friction, and patient sustainability, all without increasing complexity.